Philadelphia 2007: Prospects and Challenges

A study released by The Pew Charitable Trusts, entitled Philadelphia 2007: Prospects and Challenges, evaluates Philadelphia's strengths and weaknesses relative to six comparable American cities: Atlanta, Baltimore, Boston, Cleveland, Detroit and Pittsburgh.

The Pew-commissioned study, written by Basil J. Whiting with Tony Proscio, defines the factors that are working for and against these cities and identifies issues that most affect their future trajectories.

Download the report sections below:

 Part 1 - Forward, Acknowledgements, Background and General Findings. Pages 1 -11. (PDF, 694K)     
 Part 2 - The Philadelphia Case Study. Pages 12-31. (PDF, 521K)     
 Part 3 - Appendix 1 and Appendix 2  - Summaries of Comparison Cities and About the Authors. Pages 32-36. (PDF, 347K)

For additonal related information, see Comparative Analysis of Philadelphia Conditions and Trends, prepared by the Urban Institute.

This report was released by Pew prior to the existence of the Philadelphia Research Initiative.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.